• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail

GRN No. 422

Modified baker's yeast Saccharomyces cerevisiae

Intended Use: To reduce acrylamide production in a variety of grain-based foods, vegetable-based food (potato), and coffee and coffee substitutes at a level of 0.5 to 5 percent
Basis: Scientific procedures
Notifier: Functional Technologies Corporation
Notifier Address: Suite 1500, 885 West Georgia Street
Vancouver, British Columbia, V6C 3E8
Date of filing: Mar 5, 2012
GRAS Notice (releasable information): GRN 422 (in PDF) (1.4 MB)
Date of closure: Aug 31, 2012
FDA's Letter: FDA has no questions